CX-546 is an ampakine drug developed by Cortex Pharmaceuticals.
It has been proposed as a treatment for schizophrenia. CX-546 was the second drug of note to come out of the Cortex research program, after CX-516, but while it was an improvement over its predecessor in some respects, it still has problems with limited oral bioavailability.
However CX-546 still represented a significant advance that led on to the development of newer compounds such ...
more
Read article at Wikipedia
CX-546
top ↑
We can also tell you CX-546 is a
If you know more about CX-546, you can add more facts here »
Similar topics in Freebase
-
Sulfonmethane
Sulfonmethane (Sulfonomethane, Sulfonal, Acetone diethyl sulfone) is a chemical compound formerly used as a hypnotic drug, but now superseded by newer and safer sedatives. Its appearance is either in colorless crystalline or powdered form. In United States, it is scheduled as a Schedule III drug in... -
Aniracetam
Aniracetam (Draganon, Sarpul, Ampamet) is a nootropic compound of the racetam family purported to be considerably more potent than piracetam. It is lipid soluble and has possible cognition enhancing effects. It has been tested in animals extensively, Alzheimer's patients and temporarily-impaired... -
Paracetamol
Paracetamol (INN) (pronounced /ˌpærəˈsiːtəmɒl, ˌpærəˈsɛtəmɒl/) or acetaminophen (/əˌsiːtəˈmɪnɵfɨn/ ( listen)) (USAN) is a widely used over-the-counter analgesic (pain reliever) and antipyretic (fever reducer). It is commonly used for the relief of fever, headaches, and other minor aches and pains,... -
CX-516
CX-516 is an ampakine compound that works as an AMPA modulator and is being developed by a collaboration of Cortex and Shire and Servier. It was researched as a treatment for Alzheimer's disease, under the brand name Ampalex, and was also being examined as a treatment for ADHD. CX-516 was the first... -
Calcium glycerylphosphate
Calcium glycerylphosphate (or calcium glycerophosphate) is a mineral supplement. -
Brivaracetam
Brivaracetam, the 4-n-propyl analog of levetiracetam, is a racetam derivative with anticonvulsant properties. Brivaracetam is believed to act by binding to the ubiquitous synaptic vesicle protein SV2. Phase II clinical trials in adult patients with refractory partial seizures were promising. The... -
BOB
BOB, or 4-bromo-2,5,beta-trimethoxyphenethylamine, is a lesser-known psychedelic drug. It is the beta-hydroxy analog of 2C-B. BOB was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the dosage range is listed as 10–20 mg, and the duration listed... -
CX-614
CX-614 is an ampakine drug developed by Cortex Pharmaceuticals. It has been investigated for its effect on AMPA receptors. CX-614 produces rapid increases in release of the neurotrophic factor BDNF and may have applications in the treatment of neurodegenerative diseases such as Alzheimer's disease.... -
Methoxamine
Methoxamine is an α1-adrenergic receptor agonist, similar in structure to phenylephrine and 2,5-DMA. It induces vasoconstriction of skin and splanchnic blood vessels, thereby increasing peripheral vascular resistance and raising mean arterial blood pressure. Because of its hypertensive effects, it... -
Farampator
Farampator (CX-691, ORG-24448) is an ampakine drug. It was developed by Cortex Pharmaceuticals, and licensed to Organon BioSciences for commercial development. Following the purchase of Organon by Schering-Plough in 2007, the development license to farampator has been transferred, and development...